ADPTAdaptive Biotechnologies Corp

Nasdaq adaptivebiotech.com


$ 3.00 $ 0.08 (2.73 %)    

Friday, 03-May-2024 15:59:50 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 3.01
$ 3.13
$ 0.00 x 0
$ 0.00 x 0
$ 2.96 - $ 3.13
$ 2.28 - $ 9.08
1,093,780
na
434.59M
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 05-03-2023 03-31-2023 10-Q
5 02-14-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-03-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 02-15-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
11 08-04-2021 06-30-2021 10-Q
12 05-05-2021 03-31-2021 10-Q
13 02-24-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 02-26-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-travelers-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

 btig-maintains-buy-on-adaptive-biotechnologies-lowers-price-target-to-5

BTIG analyst Mark Massaro maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and lowers the price target from $6 to...

 adaptive-biotechnologies-names-new-cfo-preserves-strong-capital-position

Adaptive Biotechnologies announces strategic restructuring to enhance independence and financial strength.

 adaptive-biotechnologies-provides-strategic-review-update-and-announces-preliminary-q1-2024-revenue-of-41m-43m-vs-3821m-est

Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetic...

 adaptive-biotechnologies-q4-2023-adj-eps-030-beats-033-estimate-sales-4578m-miss-4846m-estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate...

 earnings-scheduled-for-february-14-2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...

 cathie-woods-ark-dumps-128m-worth-of-grayscale-bitcoin-trust-amid-crypto-rally-losing-wind-in-sails

On Monday, Cathie Wood-led Ark Invest made a significant move by selling over $12.8 million worth of Grayscale Bitcoin Trust (O...

 cathie-woods-ark-invest-trims-bitcoin-exposure-sells-29m-worth-of-gbtc-shares-amid-crypto-market-volatility

On Thursday, Cathie Wood-led Ark Invest made a significant move by selling nearly $2.9 million worth of Grayscale Bitcoin Trust...

 adaptive-biotechnologies-and-collaborators-to-present-more-than-30-abstracts-demonstrating-the-actionability-of-clonoseq-mrd-testing-in-blood-cancer-patient-care-and-drug-development-at-the-65th-ash-annual-meeting

Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetic...

 why-beyond-air-shares-are-trading-lower-by-around-37-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.

 azenta-reports-upbeat-earnings-joins-talis-biomedical-sally-beauty-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION